✦ LIBER ✦

Cost-Effectiveness Of 13-Valent Versus 23-Valent Pneumococcal Polysaccharide Vaccine And No Vaccination In The Czech National Vaccination Program

✍ Scribed by Zigmond, J.; Tichopad, A.; Kolek, V.; Roberts, C.S.; Hajek, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of 13-Valent Versus 1

✍ Tichopad, A.; Vitova, V.; Roberts, C.S.; Hájek, P. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

CE1 The Cost-Effectiveness Analysis of 1

✍ Wu, D.B.C.; Chang, C.J.; Chien, L.; Fang, H.C.H.; Roberts, C.S. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Cost-effectiveness of administering 13-v

✍ Cho, Bo-Hyun; Stoecker, Charles; Link-Gelles, Ruth; Moore, Matthew R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 621 KB

Cost-effectiveness of conjugate pneumoco

✍ Karen Richards Tyo; Melissa M. Rosen; Wu Zeng; Mabel Yap; Keng Ho Pwee; Li Wei A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 456 KB

The Immunogenicity of 7‐Valent Pneumococ

✍ Goldblatt, David; Southern, Jo; Andrews, Nick; Ashton, Lindsey; Burbidge, Polly; 📂 Article 📅 2009 🏛 University of Chicago Press 🌐 English ⚖ 309 KB

Sequential administration of 13-valent p

✍ Greenberg, Richard N.; Gurtman, Alejandra; Frenck, Robert W.; Strout, Cynthia; J 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 966 KB